AxImmune, Inc. is developing clinical stage immuno-oncology (IO) technology in-licensed from Colorado State University (CSU) and other parties. Animal studies, including at CSU and a respected independent testing lab, indicate that Ax-101 is a potent immuno-modulary agent that works synergistically with immune checkpoint inhibitors (ICI's), such as Keytruda, Yervoy, and Opdivo, improving outcomes and expanding cancers treatable with ICI drugs. Previous Ax-101 single agent human trials show no drug related adverse effects and strong anti-tumor activity. It is anticipated that co-therapy of Ax-101 and ICI drugs may significantly increase the number of patients who respond, achieve complete recovery and exhibit immunity against recurrence of the same cancer.
| Website | http://aximmune.com |
| Revenue | $5 million |
| Employees | View employees |
| Address | 320 E Vine Dr Ste 120, Fort Collins, Colorado 80524, US |
| Phone | +1 540-239-0668 |
| Industry | Drug Stores & Pharmacies, Retail |
| Competitors | Shuttle Pharmaceuticals, Inc., Bantam Pharmaceutical, Cao Pharmaceuticals Inc., Immunohelix, Frost Biologic (view competitors) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular AxImmune employee's phone or email?
AxImmune Questions
The AxImmune annual revenue was $5 million in 2026.
AxImmune is based in Fort Collins, Colorado.
The NAICS codes for AxImmune are [541714, 54171, 541, 5417, 54].
The SIC codes for AxImmune are [87, 873].
